Lab
Laboratorio Clinico Irizarry Guaschinc
Laboratorio Clinico Irizarry Guaschinc was paid $620K by Medicaid between Jul 2018 and Dec 2024, across 42 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 14% of everything it billed.
33Billing provider infoLABORATORIO CLINICO IRIZARRY GUASCHINC
AGUADILLA, PR 00603
AGUADILLA, PR 00603
33aNPI1609188283assigned 07/12/2010
33bProvider typeClinical Medical Laboratory
28Total paid$620K
24GClaims60,209
24DCodes billed42
24AFirst – last monthJul 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#214 of 777
Median peer was paid$278K
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SANCHEZ, JOSE controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,610 | $45K | |
| 2019 | 8,939 | $69K | |
| 2020 | 9,271 | $90K | |
| 2021 | 8,673 | $116K | |
| 2022 | 9,393 | $130K | |
| 2023 | 8,531 | $77K | |
| 2024incomplete | 9,792 | $94K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 14% | 2,294 | 2,084 | $87K |
| 84443 | Thyroid stimulating hormone (TSH) | 14% | 5,228 | 4,987 | $86K |
| 80061 | Lipid panel | 12% | 5,603 | 5,318 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 8,351 | 7,745 | $63K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8.5% | 2,469 | 2,206 | $53K |
| 80053 | Comprehensive metabolic panel | 8.1% | 4,872 | 4,588 | $50K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.5% | 1,236 | 1,138 | $34K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.2% | 2,719 | 2,592 | $26K |
| 81000 | 3.3% | 6,483 | 6,088 | $20K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.9% | 2,170 | 2,059 | $18K |
| 36415 | Collection of venous blood by venipuncture | 2.4% | 9,897 | 8,910 | $15K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.9% | 521 | 503 | $12K |
30 more codes
| 84439 | 1.8% | 1,261 | $11K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 277 | $10K |
| 86328 | 1.5% | 663 | $9K | |
| 82607 | 1.3% | 566 | $8K | |
| 82043 | 1.2% | 1,342 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 631 | $7K |
| 82274 | <1% | 386 | $6K | |
| 84153 | <1% | 268 | $5K | |
| 86738 | <1% | 233 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 220 | $2K |
| 85730 | <1% | 278 | $2K | |
| 82270 | <1% | 485 | $2K | |
| 87088 | <1% | 172 | $1K | |
| 86592 | <1% | 295 | $1K | |
| 82570 | <1% | 223 | $1K | |
| 85610 | <1% | 265 | $986.73 | |
| 82947 | <1% | 236 | $808.88 | |
| 85651 | <1% | 191 | $662.34 | |
| 84436 | <1% | 95 | $639.80 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $481.30 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $480.80 |
| 86140 | <1% | 45 | $227.53 | |
| 82950 | <1% | 44 | $212.38 | |
| 84460 | <1% | 30 | $111.40 | |
| 84450 | <1% | 30 | $108.77 | |
| 84156 | <1% | 27 | $108.00 | |
| 84479 | <1% | 15 | $91.65 | |
| 82565 | <1% | 23 | $70.60 | |
| 84520 | <1% | 22 | $50.36 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSANCHEZ, JOSE (PRESIDENTE)
| Provider | Location | Paid |
|---|---|---|
| Laboratorio Clinico Irizarry Guasch INC | Lajas, PR | $2.00M |
| Laboratorio Clinico Irizarry Guasch INC | Mayaguez, PR | $1.64M |
| Laboratorio Clinico Irizarry Guasch INC | Lajas, PR | $1.53M |
| Laboratorio Clinico Irizarry Guasch INC | San Sebastian, PR | $1.50M |
| Laboratorio Clinico Irizarry Guasch INC | Mayaguez, PR | $1.24M |
| Lab Clinico Irizarry Guasch INC | Mayaguez, PR | $1.11M |
| Laboratorio Clinico Irizarry Guasch INC | San German, PR | $1.03M |
| Laboratorio Clinico Irizarry Guasch INC | Cabo Rojo, PR | $723K |
| Nuevo Smile Dental Care | Nuevo, CA | $546K |
| Laboratorio Clinico Irizarry Guasch INC | Aguadilla, PR | $542K |
| Laboratorio Clinico Anexo Irizarry Guasch INC | San Sebastian, PR | $353K |
| Jose M Sanchez Dental Corporation | Pomona, CA | $59K |
| Grupo Otorrinolaringologico De PR CSP | Bayamon, PR | $21K |
| Jose Manuel Sanchez MD PA | Coral Gables, FL | $62.40 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.